The mission of the Tufts
Health Care Institute Program on Opioid Risk Management is to address challenges
in the development and utilization of opioid analgesics, by engaging a multidisciplinary
group of stakeholders focused on optimizing the benefits of opioid for pain management,
and minimizing their risks, including abuse and diversion.
May 4-5, 2012
Overview and purpose of the meeting
Nathaniel Katz, MD, MS Presentation >>
Developing an ideal analgesic:
the need now is greater than ever
Frank Vocci, PhD Presentation >>
Keynote address: the historical drive for the search for the ideal analgesic
Nancy Campbell, PhD Presentation >>
Do we still need a better analgesic: public health, public policy, and ethical perspectives
Richard Payne, MD Presentation >>
The origin and history of the National Institutes of Health/College on Problems of Drug Dependence (CPDD) medicines development program: focus on chemistry, lessons for the future
Developed by: Louis Harris, PhD
Presented by: Frank Vocci, PhD Presentation >>
Pre-clinical pharmacology approaches in the NIH Medicines Development Program and lessons for the future
James Woods, PhD Presentation >>
New approaches in the development of opioids and other analgesics
Thomas Prisinzano, PhD Presentation >>
New targets for opioids lacking
side-effects
Gavril Pasternak, MD, PhD Presentation >>
A Personal Perspective on Preclinical Drug Development
David Shelton, PhD Presentation >>
Clinical characterization of compounds at the Addiction Research Center
Donald Jasinski, MD Presentation >>
Clinical testing of analgesics: past, present and future
Nathaniel Katz, MD, MS Presentation >>
The current strategy for developing strong non-addictive pain relievers in the pharmaceutical industry
Kenneth Verburg, PhD Presentation >>
Recent progress in grassroots advocacy for addressing the opioid abuse problem
Karen Kelly Presentation >>
NIH Pain Consortium and Translational Medicine Program
Linda Porter, PhD Presentation >>
The FDA ACTTION public-private partnership: what is the FDA doing to accelerate the development of better analgesics?
Robert H. Dworkin, PhD Presentation >>
Legislative update: current efforts to increase federal spending on pain research
Robert Saner, Esq. Presentation >>
|